Posted on | CategoriesPopulation Health / Population Health Sciences / Prevention / School of Medicine | PI: Adam Bress, PharmD

Uncovering Disparities that Impact Heart Health

About 40 million adults in the United States take statin drugs to reduce their risk of heart disease and stroke. The drugs, which lower levels of LDL cholesterol, are considered safe for most people, and for many, their potential benefits are high. Many people who might benefit from statins, however, aren’t taking them. Graduate student … […] Continue reading → Uncovering Disparities that Impact Heart Health Continue reading → Uncovering Disparities that Impact Heart Health

Continue reading → Uncovering Disparities that Impact Heart Health
Posted on | CategoriesPopulation Health / Population Health Sciences | PI: Adam Bress, PharmD

Assessing and Enhancing Blood Pressure Control Protocols

Adults at high risk for cardiovascular disease who receive intensive systolic blood pressure control have significantly lower rates of death and cardiovascular disease events than those who receive standard control. However, the lifetime health benefits and health care costs associated with intensive control are not known. Continue reading → Assessing and Enhancing Blood Pressure Control Protocols

Research Statement

I am a cardiovascular clinical pharmacist with training in epidemiology and pharmacogenetics. We focus on disparities in prevention and treatment of cardiovascular disease with a focus on hypertension and antihypertensive medication use. Using pharmacoepidemiology and pharmacogenetics, we try to better understand causes of racial differences in medication responses and outcomes. We apply these findings to understand the population-level impact, generalizability, and cost-effectiveness in diverse groups.